Main Article Content
cancer-chemotherapy-induced vomiting, mild stomach upset, cough, chronic bronchial problems, and low-grade infections of all kinds and anorexia condition. This work investigates the possibility of developing Zingiber officinale oral dissolving films allowing fast, reproducible dissolution in oral cavity; thus bypassing first pass metabolism. The oral dissolving films were prepared by solvent-casting method. Prepared films were evaluated for film-forming properties, physico-mechanical properties, palatability, microbial limit test, accelerated stability studies, and clinical efficacy test. The different polymers
such as hydroxypropyl methylcellulose 5cps, maltodextrin, pullulan, and polyvinyl alcohol were explored individually and in combination with each other for the formation of film. Among all polymers, maltodextrin and HPMC 5 cps alone and
in combination showed excellent film-forming properties as well as very good physico-mechanical properties. The films resulted into excellent palatability along with least disintegrating time. But at accelerated stability studies, only HPMC 5
cps was found to be stable when compared with other formulations. So, it was concluded that HPMC 5 cps is the best film forming as well as stable polymer with respect to Zingiber officinale oral dissolving film.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
Grigoli MD. Dosage forms obtained by film coating: from transdermal
to oral forms. Available from: http://www.crsnet.org/main/chapters/
Italy/pdfs/2010SimposioDiGrigoli.pdf. [Last accessed on 2010 May 5].
Shukla D, Chakraborty S, Singh S, Mishra B. Mouth Dissolving Tablets
I: An Overview of Formulation Technology. Sci Pharm 2009;77:309-26.
Huang QR, Iwamoto M, Aoki S, Tanaka N, Tajima K, Yamahara J, et al.
Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid
isolated from ginger. Chem Pharm Bull (Tokyo) 1991;39:397-9.
Yamahara J, Rong HQ, Iwamoto M, Kobayashi G, Matsuda H. Fujimura
H. Active components of ginger exhibiting antiserotonergic action.
Phytother Res 1989;3:70-1.
Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger
powder versus placebo as an add-on therapy in children and young
adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer
Qian QH, Yue W, Chen WH, Yang ZH, Liu ZT, Wang YX. Effect of gingerol
on substance P and NK1 receptor expression in a vomiting model of
mink. Chin Med J (Engl) 2010;123:478-84.
Wu KL, Rayner CK, Chuah SK, Changchien CS, Lu SN, Chiu YC, et al.
Effects of ginger on gastric emptying and motility in healthy humans.
Eur J Gastroenterol Hepatol 2008;20:436-40.
Devi VA, Jain N, Valli KS. Importance of novel drug delivery systems
in herbal medicines. Pharmacog Rev 2010;4:27-31.
Dixit RP, Puthli SP. Oral strip technology: Overview and future potential.
J Control Release 2009;139:94-107.
Patel R, Naik S, Patel J, Baria A. Formulation development and
evaluation of mouth melting films of ondensetron. Arch Pharm Sci
Tingstad JE. Physical stability testing of pharmaceuticals. J Pharm Sci
Dzija M, Barkalow D, Chapdelaine A, Zyck D. Edible film formulations
containing maltodextrin. US PATENT 2003/0035841. 2003.
Shinde AJ, Garala KC, More HN. Development and characterization of
transdermal therapeutics system of tramadol hydrochloride. Asian J